Versus Systems, ProQR, and Santech Holdings are the 3 Penny Stocks to watch on October 17, 2024, based on TipRanks’ Penny ...

Wave's RNA editing technology appears to have highly potential for the treatment of AATD, a genetic disorder with potential ...

Wave Life Sciences reports that it has successfully carried out RNA editing in two patients with alpha-1 antitrypsin ...

US RNA medicines biotech Wave Life Sciences yesterday announced positive proof-of-mechanism data from the ongoing Phase ...

Wave claims this is the first clinical data with a therapeutic RNA-editing drug in humans, an achievement that boosted its ...

Joseph Schwartz, an analyst from Leerink Partners, reiterated the Buy rating on Wave Life Sciences (WVE – Research Report). The ...

Chardan Capital analyst Keay Nakae has reiterated their bullish stance on ADVM stock, giving a Buy rating on October 14. Keay Nakae has given ...

While RNA-medicine developer Wave Life Sciences Ltd. brought in a clinical data win, it also got knocked back a step as a major collaborator will go its separate way. That didn’t stop Wave’s stock ...

Wave Life Sciences' alpha-1 antitrypsin deficiency candidate WVE-006 succeeded in the first-ever clinical demonstration of ...

Wave Life Sciences' WVE-006 study shows significant promise in treating alpha-1 antitrypsin deficiency. Learn more about WVE ...

An experimental therapy designed to change a single letter of short-lived mRNA molecules has corrected a genetic mutation ...